Nixse
0

Surescripts in a Battle with Amazon

Surescripts is a company that allows electronic prescribing of drugs. And now, the firm is raising its battle against Amazon-owned PillPack.

Aside from that, the e-prescription company accused the firm of giving

PillPack with patient prescription information fraudulently. The company terminated a contract with a vendor which improperly ask access to patient’s medication histories to give to PillPack. Surescripts will now put the matter in the hands of the FBI. Also, this is the latest move that light put Amazon in a harder place to enter the prescription drug industry.

In addition to that, Surescripts, which owned by the two largest pharmacy-benefit managers, announced on Monday that it had signaled the FBI for the issue.

In 2018, Americans were paying an excessive amount on the prescription of drugs. And the amount spent reached as much as $330 billion. Moreover, in the same year, Amazon made its first step into the market as it acquired PillPack, an online pharmacy start-up.

Then, Amazon faced an intense battle with one of the largest firms in the space. An alliance of potential PillPack competitors such as CVS and ExpressScripts owned Surescripts. And it manages around 80% of all prescriptions in the U.S.

The company became a powerful force. As a result, in April, the Federal Trade Commission sued Surescripts, saying it illegally monopolized the e-prescription industry.

The Battles of Surescripts

Meanwhile, the battle is the most recent matter in the string of dispute between Amazon and the established pharmacy companies since the PillPack deal. And this deal put shares of pharmacy owners and pharmacy benefit managers to plunge.

Furthermore, CVS filed a lawsuit against a former employee earlier this year. And this was following its announcement to the company that he will take a job at PillPack. Then, a judge halted the employee from working for PillPack for as long as 18 months.

  • Support
  • Platform
  • Spread
  • Trading Instrument
Comments Rating 0 (0 reviews)


You might also like

Leave a Reply

User Review
  • Support
    Sending
  • Platform
    Sending
  • Spread
    Sending
  • Trading Instrument
    Sending